2026 Regular Session
HB 2081
Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program
In Committee
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Sponsors
Official sponsors from legislative records.
Primary sponsor
Ben Keathley
HouseMORepublicanDistrict 101
Cosponsor
Bob Titus
HouseMORepublicanDistrict 139
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.